摘要
目的:探讨血脂、脂蛋白、载脂蛋白(apo)AⅠ、AⅡ、B、CⅡ、CⅢ、E在脑血管病发病中的意义及其作用。方法:选择脑梗塞病人165例,脑出血病人135例,健康对照组30例,空腹采静脉血,测定血脂蛋白谱。结果:脑梗塞病人Lp(a)显著增高,高密度脂蛋白-C(HDL-C)、apoAⅠ显著降低,脑出血病人apoE显著增高。脑梗塞与脑出血共同存在着apoAⅠ/apoB比值降低,apoAⅠ、HDL-C、apoCⅡ的降低及甘油三酯(TG)、apoCⅢ、低密度脂蛋白-C(LDL-C)的升高。逐步回归分析优选风险度指标:脑梗塞首选Lp(a),脑出血首选apoE,脑血管病首选apoAⅠ/apoB。结论:脑血管病病人存在着血脂代谢的异常,脑梗塞与脑出血的血脂代谢存在差异。应对脑血管病病人进行血脂干预性治疗。
A study was performed to determine whether differences existed in regard to serum lipid lipoprotein and apolipoprotein AⅠ, AⅡ,B,CⅡ,CⅢ,E in cerebrovascular diseases. Method:165 patients with cerebral infarction 135 patients with cerebral hemorrhage and 30 normal controls were selected to have their serum lipoprotein examined. Lp(a) were analyzed with well stardardized ELISA methods. All the Apo were determined by immunoturbidimetric methods. Results:[HTSS]patients with cerebral infarction and cerebral hemorrhage had either high levels of TG, apoCⅢ & LDLC or low levels of apoAⅠ/apoB,HDLC, apoCⅡ. Increased level of Lp(a), decreased level of HDLC and decreased level of apoAⅠ are the risk factors of cerebral infarction, increased level of apoE is the risk factor of cerebral hemorrhage. Progressive regression analysis selected Lp(a)is the first choice of discriminator for cerebral infarction, apoE for cerebral hemorrhage, apoⅠ/apoB for cerebrovascular diseases.
出处
《北京医学》
CAS
北大核心
1998年第4期272-275,共4页
Beijing Medical Journal